FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/10/096081 [Registered on: 14/10/2025] Trial Registered Prospectively
Last Modified On: 30/09/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Are children and adolescents living with nephrotic syndrome at higher risk for developing hypertension ? 
Scientific Title of Study   Profile of Continuous ambulatory blood pressure monitoring in children and adolescents with nephrotic syndrome 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Shrishti Rai 
Designation  Post Graduate Student 
Affiliation  Maulana Azad Medical College 
Address  Department of pediatrics, Maulana Azad Medical College and associated Lok Nayak Hospital

Central
DELHI
110002
India 
Phone  8510037567  
Fax    
Email  shristirai25@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Mukta Mantan 
Designation  Director Professor 
Affiliation  Maulana Azad Medical College 
Address  2nd floor Department of Pediatrics Maulana Azad Medical College and associated Lok Nayak Hospital

Central
DELHI
110002
India 
Phone  9968604315  
Fax    
Email  muktamantan@hotmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Shrishti Rai 
Designation  Post Graduate Student 
Affiliation  Maulana Azad Medical College 
Address  Department of Pediatrics Maulana Azad Medical College and associated Lok Nayak Hospital

Central
DELHI
110002
India 
Phone  8510037567  
Fax    
Email  shristirai25@gmail.com  
 
Source of Monetary or Material Support  
Maulana Azad Medical College and associated Lok Nayak, G.B Pant and G.N.E.C hospitals, New Delhi - 110002 Delhi India  
 
Primary Sponsor  
Name  Dr Mukta Mantan 
Address  Director Professor Department of Pediatrics Maulana Azad Medical College and associated Lok Nayak Hospital New Delhi- 110002 India 
Type of Sponsor  Other [Individual] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 2  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shrishti Rai  Department of Cardiology  G B Pant institute of postgraduate medical education and research hospital
Central
DELHI 
8510037567

shristirai25@gmail.com 
Dr Shrishti Rai  Department of Pediatrics  Maulana Azad Medical College and associated Lok Nayak Hospital
Central
DELHI 
8510037567

shristirai25@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics committee Maulana Azad Medical College New Delhi-110002  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N04||Nephrotic syndrome,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  10.00 Year(s)
Age To  18.00 Year(s)
Gender  Both 
Details  All children and adolescents detected with steroid sensitive or steroid resistant nephrotic syndrome having the disease for at least last two years and are in partial or complete remission 
 
ExclusionCriteria 
Details  1. Children with eGFR less than 60 ml per min per
1.73 meter squares.
2. Children diagnosed with diabetes mellitus, familial hyperlipidemia syndromes, stage 2 or more of hypertension.
3. Children with nephrotic syndrome who had infrequently relapsing course throughout.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Determination of mean systolic, diastolic blood pressures during day and night time using continuous ambulatory blood pressure monitor for detection of hypertension or masked hypertension.
Identifying systolic and diastolic loads over a 24 hours period and nocturnal dipping in study population. 
baseline and for next 24 hours 
 
Secondary Outcome  
Outcome  TimePoints 
Association of hypertension with duration, type & treatment (dosage & duration of steroids, calcineurin inhibitors, antihypertensives) of nephrotic syndrome.
Proportion of patients with left ventricular hypertrophy. 
baseline 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/10/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Nephrotic syndrome is the most frequent pediatric glomerular disease, affecting from 1.15 to 16.9 per 100,000 children per year globally , characterized by alterations of perm-selectivity at the glomerular capillary wall, resulting in its inability to restrict the urinary loss of protein and manifested as edema, hypoalbuminemia and hyperlipidemia. Almost 80 percent of the children with nephrotic syndrome (NS) have steroid sensitive disease and show minimal changes on renal histology and respond to steroid therapy. Most patients both with steroid sensitivity or steroid resistant nephrotic syndrome receive oral prednisolone for prolonged periods. Besides, hypercholesterolemia is a ubiquitous finding in nephrotic syndrome, the magnitude of dyslipidemia directly correlates with the severity of proteinuria. Children with nephrotic syndrome have been shown to be at a higher risk of hypertension due to the underlying condition, use of corticosteroids for prolonged periods and use of medications like calcineurin inhibitors. Ambulatory hypertension, abnormalities in blood pressure (BP) circadian rhythm, and measures of BP variability are prevalent in patients with NS. Left ventricle hypertrophy (LH) is strongly associated with hypertension in children, especially with masked hypertension. Hence, casual blood pressure monitoring alone is insufficient for detection of hypertension induced LVH. Continuous ambulatory blood monitoring (CABPM) measures blood pressure for 24 hours during normal physical activity rather than a single instant, thus allowing assessment of 24 hour blood pressure profile of a patient and nocturnal dipping which is often lost early prior to the onset of overt hypertension in children and adults. For methodology of the study, an informed consent and or assent will be taken from patient and caregivers before enrolling for the study. A study Performa shall be filled that will include baseline information (age, diagnosis, duration of NS, treatment details) of the patient. A detailed examination and anthropometry will be done and recorded Anthropometry values (weight, height, BMI) will be categorized using India Academy of Pediatrics charts. Biochemical investigations including hemogram, kidney function tests, serum albumin, lipid profile, HbA1c will be done at baseline for all patients by drawing a 2ml blood sample. Casual BP will be measured and patient will be admitted for 24 hours for Continuous ambulatory blood pressure monitoring using CABPM device AND TM2441 which will record BP readings every 30 minutes during daytime and every 1 hour at night for a 24 hours period using an optimum Pediatric size cuff placed on the non-dominant arm of the patient. An echocardiography for detection of left ventricular hypertrophy will be done for all patients and the indices that will be measured are- interventricular septal thickness, LV posterior wall thickness and LV mass index. BP loads will be calculated from the data-(percentage of readings above the ambulatory 95th percentile for both SBP and DBP during the entire 24-hour awake and sleep periods). The cut off for CABPM values will be taken from the references provided by the German Collaboration Group (Aged 6 yr or > 120cm height). Based on these results the patients would be categorized into different categories of hypertension.

  


 
Close